PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6254801

Prospects for improved contraception.

L Atkinson·S B Schearer·O Harkavy·R Lincoln
View original source ↗Export metadata ↓

Abstract

Some important new birth control methods have been developed in the postpill, post-IUD era; others are on the way. But shrinking dollars in research (especially R&D), inadequate coordination and planning by donors and programs, and costly and complex regulatory requirements frustrate efforts to use current knowledge to make major breakthroughs.

Explore related subjects

Contraceptive AgentsContraceptive DevicesFemaleHumansIntrauterine DevicesMaleMenstruation-Inducing AgentsSterilization, TubalVaccinesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L Atkinson, S B Schearer, O Harkavy, R Lincoln. Prospects for improved contraception.. https://pubmed.ncbi.nlm.nih.gov/6254801/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Development of the selective progesterone receptor modulator CDB-2914 for clinical indications.

CDB-2914 (17 alpha-acetoxy-11 beta-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione) is a 19-norprogesterone derivative that acts as an antagonist in progesterone-responsive tissues. It binds to progesterone receptors A and B with high affinity. After oral dosing in humans, CDB-2914 serum levels peak at 60-90 min. CDB-2914 binds to serum proteins and is cleared slowly. Doses of 1, 10 and 50 mg exhibit proportional increases in peak serum levels, but serum levels from higher doses, 100 and 200 mg, are not dose-dependent, suggesting saturation of carrier sites. The biological effects of CDB-2914 vary according to time of the menstrual cycle that the drug is given. In the mid-follicular phase, CDB-2914 (50 mg) inhibits follicular development and delays ovulation and menses. At 100 mg, in some cases the original follicle ceases development and a new follicle is recruited. Endometrial maturation is delayed at all doses tested (10, 50, 100 mg). Given at mid-luteal phase, there was a dose-dependent effect on menses, with higher doses (100-200 mg) resulting in earlier menses. On average, CDB-2914 tends to lengthen the menstrual cycle by approximately 1-2 days although the amount of delay varies with timing in the menstrual cycle and dose.

Contraceptive Agents↗
PubMed2003

Unmet need and unintended fertility: longitudinal evidence from upper Egypt.

CONTEXT: Although unmet need for family planning is a standard measure for evaluating programs' effectiveness in meeting the reproductive needs of individuals, its validity and accuracy in identifying women most at risk of unintended pregnancy have been questioned. METHODS: Women who participated in the 1995 Egypt Demographic and Health Survey in two governorates in Upper Egypt (Assuit and Souhag) were followed for two years (N=2,444); in-depth data on their fertility preferences, contraceptive use and births were gathered in 1996 and 1997. Transitions among contraceptive need categories from 1995 to 1997 are examined, and rates of unintended (mistimed and unwanted) births are calculated according to contraceptive need status at baseline. RESULTS: In the aggregate, unmet need increased by six percentage points, from 28% to 34%. This change was the net outcome of 14% moving out of unmet need and 20% moving into unmet need (i.e., substantial satisfaction of unmet need was offset by increased demand for contraception). The rate of unintended fertility was far higher among women with unmet need at baseline than among contraceptive users in 1995. Women with unmet need made up about one-quarter of the baseline sample, but they contributed almost one-half of mistimed and unwanted births during the two years. The majority of unintended births were to women who had never practiced contraception, whereas fewer than one-fifth were to women with recent contraceptive experience (including contraceptive failure). CONCLUSIONS: : Unmet need for family planning remains a useful tool for identifying and targeting women at high risk of unintended pregnancy.

Contraceptive Agents↗